|
Market Closed -
Hong Kong S.E.
09:08:13 22/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 20.88 HKD | +4.56% |
|
+10.71% | -31.50% |
| 08-27 | Medtide Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 07-31 | Medtide Names CFO | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 361M | - | - | |||
| 46.68B | |||||
| 44.42B | |||||
| 41.32B | - | - | - | - | - |
| 41.58B | |||||
| 30.14B |
- Stock Market
- Stocks
- 3880 Stock
- Charts Medtide Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
